Full-Time

Senior Manager

Medical Affairs Cell Therapy, Franchise Strategy and Operations, Project Manager

Posted on 5/20/2025

Deadline 7/29/25
Bristol Myers Squibb

Bristol Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

No salary listed

Senior

Company Historically Provides H1B Sponsorship

Princeton, NJ, USA

Hybrid role requiring at least 50% onsite presence.

Category
Project Management
Medical, Clinical & Veterinary
Biology & Biotech
Business & Strategy
Required Skills
SAP Products
Tableau
Risk Management
Data Analysis
Excel/Numbers/Sheets
Requirements
  • BS/BA required
  • 5+ years industry experience required (research in pharmaceutical, biotechnology, or academics is preferred)
  • Advanced project management skills and relevant experience on matrix management, budget management, metrics, senior leadership communication (Commercial, R&D experience a plus)
  • Ability to lead and engage in complex strategic scientific discussions to develop/summarize clear follow-up/action plans, to execute and drive performance
  • Ability to build relationships, influence and drive organizational engagement at all levels in a rapidly changing environment
  • Highly effective written/verbal communication and interpersonal skills
  • Highly organized and motivated individual with the ability to work independently/effectively with cross functional matrixed teams
  • Strong technical skills, including advanced Excel, Sharepoint, TEAMS and other analytics & business intelligence and finance (Tableau, Ariba, SAP, Workday, Room scheduler, COMPASS, etc.) strongly desired
  • Comfort with ambiguity, driving change and innovation across a matrix
Responsibilities
  • Plan, develop and execute strategic reviews for Medical and Budget Planning across the therapeutic areas within Cell Therapy Medical
  • Manage the Cell Therapy Medical Monthly Dashboard, including creating, populating, and streamlining content, while ensuring metric based updates align with the organization’s strategic objectives
  • Serve as the single point of contact for congress operations for the Cell Therapy Medical organization, including tracking attendance/rationale across the therapeutic within allocations provided
  • Prepare detailed project plans, progress reports, and presentations for senior management and other stakeholders, as needed
  • Track & measure performance and identify risk areas or barriers impeding successful execution. Work with teams, Medical leadership, and/or senior management to resolve
  • Ensure agendas for key meetings are focused on key deliverables, risk management, issue identification and resolution. Ensure that key actions and agreements are understood, and the team is held accountable for their commitments
  • Partner with Finance and Medical leads to facilitate the budget process including trade-off discussions and on an ongoing basis ensure the brand budgets (including facilitation of annual budget, monthly projections, accruals, variance analysis and budget planning for the coming year) are on track
  • Identify, develop and implement new processes to facilitate continued evolution of the Operations function and improve efficiency of the Medical organization
  • Build relationships with key stakeholders, Commercial, Hematology and Cell Therapy Medical team members, to influence strategic alignment on key Medical objectives
  • Ensure Medical Team members are fully represented in the decision-making process and knowledge exchange is taking place
  • Ensure key communication points/metrics are captured and disseminated (dashboards, tracking scientific communications)
  • Train/Onboard of new project managers, junior level support, and/or contingent workers
Desired Qualifications
  • Experience with drug development, commercialization, and healthcare, clinical trial management a plus

Bristol Myers Squibb (BMS) develops and delivers medicines for serious diseases, focusing on oncology, immunology, and cardiovascular conditions. The company invests heavily in research and development to create new drugs, which are sold to hospitals and patients after receiving regulatory approval. BMS also produces affordable generic drugs and supports the development of biosimilars, ensuring access to quality healthcare. Their goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's $40B US investment signals strong commitment to growth despite cost-cutting.
  • AI partnership with Optellum enhances early lung cancer diagnosis and precision care.
  • Expansion in Gulf region under new leadership boosts market presence and opportunities.

What critics are saying

  • Layoffs and facility closures may disrupt production and market demand fulfillment.
  • New leadership appointments could shift company policy, impacting ongoing projects.
  • Acquisition of 2seventy bio may pose integration challenges affecting operational efficiency.

What makes Bristol Myers Squibb unique

  • BMS focuses on oncology, immunology, and cardiovascular diseases, setting it apart in biopharma.
  • The company invests heavily in R&D to develop innovative and generic medicines.
  • BMS emphasizes sustainability and ESG goals, enhancing its corporate responsibility image.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Company News

BioSpace
May 6th, 2025
BMS Pledges $40B Investment in US Despite Cost-Cutting Plans

This year alone BMS has laid off more than 800 employees, the bulk of which were just revealed this month, putting 516 jobs on the chopping block.

ROI-NJ
May 6th, 2025
Bristol Myers Squibb Names Gallman Executive Vp, General Counsel And Chief Policy Officer

Bristol Myers Squibb, the fourth-largest company in New Jersey by market cap, announced Tuesday the appointment of Cari Gallman as executive vice president, general counsel and chief policy officer, effective immediately. She succeeds Sandra (Sandy) Leung, who is retiring after a 33-year career at the company.Gallman has extensive experience in pharmaceutical law and compliance. She will lead the law department, which includes intellectual property, commercial and regulatory law, litigation, securities and corporate governance, transactions, corporate security and compliance and ethics, as well as global and U.S. policy and government affairs. Gallman has held leadership positions at Bristol Myers Squibb for 10 years, most recently serving as executive vice president, corporate affairs.“I am committed to continuing to build on the company’s culture of integrity and shape a dynamic policy environment that protects innovation and patients,” said Gallman in a statement.Gallman began her legal career in private practice representing pharmaceutical and medical device manufacturers in civil, regulatory, and government enforcement matters.She earned a bachelor’s degree in political theory from Princeton University, magna cum laude, and holds a juris doctor degree from Harvard Law School

Endpoints News
May 5th, 2025
Bristol Myers to lay off over 500 workers in New Jersey

Bristol Myers to lay off over 500 workers in New Jersey.

NJBIZ
May 5th, 2025
Bristol Myers Squibb plans 500+ layoffs in NJ

BMS recently announced plans to close a manufacturing facility in Illinois that handles viral vector production.

All Blog Things
May 3rd, 2025
BMS to lay off 516 employees at its Lawrence Township facility

BMS to lay off 516 employees at its Lawrence Township facility.